Il Felbamato nel trattamento delle epilessie resistenti in eta pediatrica

Translated title of the contribution: Felbamate as add-on in drug-resistant epilepsies of childhood

M. R. Cilio, R. Bonardi, F. Vigevano

Research output: Contribution to journalArticlepeer-review


FBM is a new antiepileptic drug that has been administered as add-on therapy in 14 pediatric patients affected by drug-resistant partial or generalized epilepsies. FBM reduced significantly the total seizure frequency in 40% of subjects and it appear to be well tolerated. The improvement has persisted for up to 12 months.

Translated title of the contributionFelbamate as add-on in drug-resistant epilepsies of childhood
Original languageItalian
Pages (from-to)197-199
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number95-96
Publication statusPublished - 1996

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Felbamate as add-on in drug-resistant epilepsies of childhood'. Together they form a unique fingerprint.

Cite this